Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/REGENERON-PHARMACEUTICALS-10649/news/EVKEEZA-EVINACUMAB-PHASE-3-TRIAL-DEMONSTRATES-48-LDL-C-REDUCTION-IN-CHILDREN-WITH-ULTRA-RARE-FORM-40517412/?utm_source=whatsapp&utm_medium=social&utm_campaign=share